2025-11-04 – Press Releases – www.prnewswire.com
SHANGHAI, Nov. 4, 2025 /PRNewswire/ — Hasten Biopharmaceutical Co., Ltd. (“Hasten”) announced that while completing 70 Marketing Authorization Transfers (MAT) for its Asia-Pacific product portfolio, the company has established an end-to-end commercial network covering Southeast Asia,…
